Korro Bio was founded to turn extraordinary scientific insights into life-altering new treatments for patients. We harness the body’s natural RNA editing machinery to make precise, single-base RNA edits to modulate protein function, addressing the medical needs of patients. Our mission is to rewrite the future for patients living with debilitating disease by repairing the underlying genetic cause.
View Top Employees from Korro Bio, Inc.Website | http://www.korrobio.com |
Revenue | $1 million |
Employees | 105 (105 on RocketReach) |
Founded | 2018 |
Address | One Kendall Square, Building 600-700, Suite 6-401, Cambridge, Massachusetts 02139, US |
Technologies |
JavaScript,
HTML,
PHP
+26 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Drug Discovery, Business Services, Biotechnology |
Keywords | Rare Disease, Rna Therapeutics, Genetic Testing, Precision Medicine, Innovative Medicine |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 541 Companies, NAICS Code 54171 Companies, NAICS Code 541714 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies |
Looking for a particular Korro Bio, Inc. employee's phone or email?
The Korro Bio, Inc. annual revenue was $1 million in 2024.
Ram Aiyar is the CEO of Korro Bio, Inc..
105 people are employed at Korro Bio, Inc..
Korro Bio, Inc. is based in Cambridge, Massachusetts.
The NAICS codes for Korro Bio, Inc. are [541, 54171, 541714, 54, 5417].
The SIC codes for Korro Bio, Inc. are [873, 87].